ALK-positive NSCLC: the role of treatment selection and sequencing
Benjamin Besse • 19 Oct 2018
A new role for pharmacists in the personalized treatment of cancer patients?
Christine Walko • 21 Mar 2018
More focus is needed on subtypes of lung cancer that do not have FDA-approved targeted therapies
Ross Camidge • 21 Mar 2018
The successes of novel therapies and molecular testing in lung cancer and patient access
Janet Freeman-Daily • 4 Dec 2016